Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules.
...
Yondelis may now be considered an important new option to control advanced sarcomas in patients after failure of available standard-of-care therapies.
...